Cargando…

Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice

Atherosclerosis is a progressive inflammatory vascular disorder, complicated by plaque rupture and subsequently atherothrombosis. In vitro studies indicate that key clotting proteases, such as factor Xa (FXa), can promote atherosclerosis, presumably mediated through protease activated receptors (PAR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Posthuma, Jelle J., Posma, Jens J. N., van Oerle, Rene, Leenders, Peter, van Gorp, Rick H., Jaminon, Armand M. G., Mackman, Nigel, Heitmeier, Stefan, Schurgers, Leon J., ten Cate, Hugo, Spronk, Henri M. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405752/ https://www.ncbi.nlm.nih.gov/pubmed/30846818 http://dx.doi.org/10.1038/s41598-019-40602-w

Ejemplares similares

Coagulation Factor Xa Induces Proinflammatory Responses in Cardiac Fibroblasts via Activation of Protease-Activated Receptor-1
por: D’Alessandro, Elisa, et al.
Publicado: (2021)

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
por: Henskens, Yvonne M. C., et al.
Publicado: (2018)

Annexin A5 reduces early plaque formation in ApoE -/- mice
por: Stöhr, Robert, et al.
Publicado: (2017)

Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment
por: ten Cate, Hugo, et al.
Publicado: (2020)

Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes
por: Sommeijer, Dirkje W, et al.
Publicado: (2005)

Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease
por: Olie, Renske H., et al.
Publicado: (2019)

Integrating Mechanisms in Thrombotic Peripheral Arterial Disease
por: Nagy, Magdolna, et al.
Publicado: (2022)

Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
por: van de Berg, Tom W., et al.
Publicado: (2021)

Blood coagulation and the risk of atherothrombosis: a complex relationship
por: Spronk, Henri MH, et al.
Publicado: (2004)

Vitamin K antagonist use induces calcification and atherosclerotic plaque progression resulting in increased hypercoagulability
por: van Gorp, Rick H, et al.
Publicado: (2021)

Coagulation Factor Xa
por: Brown, Mark A., et al.
Publicado: (2013)

Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
por: Grottke, Oliver, et al.
Publicado: (2013)

Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease
por: Kremers, B. M. M., et al.
Publicado: (2022)

Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background
por: van Paridon, Pauline C. S., et al.
Publicado: (2022)

Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner
por: Borissoff, Julian I., et al.
Publicado: (2013)

Roles of factor Xa beyond coagulation
por: Ruf, Wolfram
Publicado: (2021)

New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)
por: van Gorp, Rick H., et al.
Publicado: (2015)

Evaluation of the analytical performance of the PC100 platelet counter
por: Nagy, Magdolna, et al.
Publicado: (2021)

Thrombin Generation in the Glasgow Myocardial Infarction Study
por: Smid, Machiel, et al.
Publicado: (2013)

The hypercoagulable profile of patients with stent thrombosis
por: Loeffen, R, et al.
Publicado: (2015)

The Role of Vascular Smooth Muscle Cells in Arterial Remodeling: Focus on Calcification-Related Processes
por: Jaminon, Armand, et al.
Publicado: (2019)

ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin‐6
por: Willems, Loes H., et al.
Publicado: (2021)

Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events
por: Loeffen, Rinske, et al.
Publicado: (2016)

Calibrated automated thrombogram II: removing barriers for thrombin generation measurements
por: Giesen, P. L. A., et al.
Publicado: (2021)

Platelet Dysfunction in Thrombosis Patients Treated with Vitamin K Antagonists and Recurrent Bleeding
por: van der Meijden, Paola E. J., et al.
Publicado: (2013)

Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease
por: Kremers, Bram M. M., et al.
Publicado: (2019)

Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021)

Thrombin generation by calibrated automated thrombography in goat plasma: Optimization of an assay
por: D'Alessandro, Elisa, et al.
Publicado: (2021)

Dabigatran and apolipoprotein B
por: ten Cate, Hugo
Publicado: (2016)

Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity
por: Kuiper, Gerhardus J. A. J. M., et al.
Publicado: (2016)

A new method to determine tissue specific tissue factor thrombomodulin activities: endotoxin and particulate air pollution induced disbalance
por: Frederix, Kim, et al.
Publicado: (2008)

Thrombin and factor Xa link the coagulation system with liver fibrosis
por: Dhar, Ameet, et al.
Publicado: (2018)

Composition of PM Affects Acute Vascular Inflammatory and Coagulative Markers - The RAPTES Project
por: Strak, Maciej, et al.
Publicado: (2013)

The coagulation system in atherothrombosis: Implications for new therapeutic strategies
por: Olie, Renske H., et al.
Publicado: (2018)

Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo
por: Perzborn, E, et al.
Publicado: (2014)

Integrating platelet and coagulation activation in fibrin clot formation
por: Swieringa, Frauke, et al.
Publicado: (2018)

Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation
por: Brouns, Sanne L. N., et al.
Publicado: (2020)

The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study
por: Gulpen, Anouk J. W., et al.
Publicado: (2019)

Vascular Function, Systemic Inflammation, and Coagulation Activation 18 Months after COVID-19 Infection: An Observational Cohort Study
por: Willems, Loes H., et al.
Publicado: (2023)

Vascular protective effect of aspirin and rivaroxaban upon endothelial denudation of the mouse carotid artery
por: Mastenbroek, T. G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qh07oceoem6rk9mnr2spsg3e17